Discover New Secrets to a successful business venture

Scott Rocklage  Dr. Scott Rocklage has become an instrument when it comes to medical research and entrepreneurship. He has carved his niche in pharmaceuticals, investment management, and in health car

Dr. Scott Rocklage has become an instrument when it comes to medical research and entrepreneurship. He has carved his niche in pharmaceuticals, investment management, and in health care.

Dr. Scott is now the managing partner at 5AM Ventures, he joined the firm in 2003 and rose to management position one year later. 5AM Ventures got its name from its primary operations, where they help develop new businesses interested in life science.

The company is interested in businesses seeking to find solutions to life’s problems through science. This is where Scott comes in. He helps them refine their concepts to solve the human pains.

Before joining 5AM Ventures, 61-year old Scott once worked in the following firms;

As chairman and CEO at Cubist Pharmaceuticals

President and CEO of Nycomed Salutar

Various leadership posts as R&D of Catalytica and Salutar

Executive chairman at Miikana and Ilysa

He also now serves on the management Boards of Achaogen, Semprus, and Relypsa and also on the boards of ;

WavsRx

Pulmatrix

Kinestral

Rennovia

Cidara among other companies.

The extensive list only spells one thing; Dr. Scott has something to offer, and whatever he touches, turns into platinum. Read more: Scott Racklage | Crunchbase and Scott Rocklage | LinkedIn

That’s what he is now doing with 5AM Ventures. It is now the hottest cake in the science market where business who recognizes Scotts typical values and contributions are yearning to work with him.

Dr. Scott’s success in science world is attributed to his rich education background. He is a proud holder of a Doctor of Philosophy in Chemistry from Massachusetts Institute of Technology. He did his degree in Chemistry at the University of California.

He has achieved imminence success in pharmaceuticals; three of his drugs were approved by US FDA. The drugs are Omniscan®, Teslascan®, and Cubicin®. Besides these, he has carried other six successful laboratory trials.

Scott also owns and co-own over 30 Patent rights across the United States and over 100 research papers published under his name.

His perfections can be associated with his love for every detail and time keeping. Dr. Scott follows his priorities to the letter and only works with a competent team.

At 5AM Ventures, he insists on hiring only qualified staff with diverse skill set necessary to successfully maneuver the hectic life science field.

Dr. Scott was delighted when the news emerged that scientist has achieved a breakthrough in quest to find solution to cancer, the deadliest disease in the world. He observed that the victims can now live.